1. Mechanisms and Efficacy of Chinese Herbal Medicines in Chronic Kidney Disease
   Mingming Zhao et al, 2021, Front. Pharmacol. CrossRef
2. Research Progress of Chinese Herbal Medicine Intervention in Renal Interstitial Fibrosis
   Xiao-Yuan Liu et al, 2022, Front. Pharmacol. CrossRef
3. Gentiopicroside Ameliorates Diabetic Renal Tubulointerstitial Fibrosis via Inhibiting the AT1R/CK2/NF-κB Pathway
   Zhanchi Xu et al, 2022, Front. Pharmacol. CrossRef
4. Natural products: potential drugs for the treatment of renal fibrosis
   Zijun Zhou et al, 2022, Chin Med CrossRef
5. Astragalus Mongholicus: A review of its anti-fibrosis properties
   Fengying Gong et al, 2022, Front. Pharmacol. CrossRef
6. Heidihuangwan alleviates renal fibrosis in rats with 5/6 nephrectomy by inhibiting autophagy
   Ying-Ying Li et al, 2022, Front. Pharmacol. CrossRef
7. The Molecular Basis of the Anti-Inflammatory Property of Astragaloside IV for the Treatment of Diabetes and Its Complications
   Lin Li et al, 2023, DDDT CrossRef
8. Saponin monomers: Potential candidates for the treatment of type 2 diabetes mellitus and its complications
   Lvzhuo Zhang et al, 2024, Phytotherapy Research CrossRef